A questionnaire survey was conducted of 310 consultant cardiac anaesthetists in the United Kingdom. We asked which nondepolarising muscle relaxants they preferred for fast-track and non-fast-track patients, and how neuromuscular function was assessed prior to extubation.
Introduction
This survey examines current practice regarding the use of non-depolarising muscle relaxants (NDMRs) in adult cardiac anaesthesia in the UK. It arose following work at our unit examining the duration of action of NDMRs (pancuronium and rocuronium) in adult patients undergoing fast-track cardiac surgery [1] . The definition of 'fast-track' varies in different cardiac units, but the basis is a shorter time to extubation than has traditionally been the case.
This and other published work [2] [3] [4] indicate that the use of long-acting NDMRs in adult cardiac anaesthesia is associated with residual neuromuscular blockade at the time of planned extubation. Other studies [5] [6] [7] [8] [9] have demonstrated that post-operative residual neuromuscular blockade is associated with an increase in morbidity and mortality.
This survey was designed to answer a number of questions:
• Which NDMR's are used in both fast-track and non-fast-track cardiac anaesthesia in the UK?
• What factors affect the choice of NDMR in fast-track and non-fast-track patients?
• Does the type of management (i.e. fasttrack versus non-fast-track adult cardiac anaesthesia) influence the choice of NMDR?
• Is the neuromuscular blocking effect of these drugs monitored prior to extubation? And if so, how?
Method

Questionnaire
The questionnaire comprised a variety of styles of question and is included as Appendix 1. Advice on questionnaire design was obtained from a medical statistician.
Responders occasionally indicated more than one NDMR as 'first choice' in response to questions two and four and data input was adjusted to allow these responses. Reasons for NDMR choice were related to first choice of NDMR. Answers to question two and four were analysed to examine change in practice between fast-track and non-fast-track patients.
Microsoft Excel was used for database management. Fisher's exact test was used for all tests of significance (StatXact version 4, Cytel Software Corp, 675 Massachusetts Avenue, Cambridge, MA 02139 USA).
anaesthetists who regularly provide anaesthesia for adult cardiac surgery in the UK. We defined 'regular involvement' as being involved in at least one list containing adult cardiac patients per week.
A total of 225 anaesthetists returned questionnaires from the 310 distributed (a response rate of 73%). Six anaesthetists indicated they are involved in less than one cardiac surgical list per week, one questionnaire was returned blank and one was spoilt. A total of 217 responses were therefore available for further analysis.
Results
Choice of NDMR for fast-track and nonfast-track patients is presented in Figure  1 . There was one blank response for non-fast-track patients and four blank and two spoilt responses for fast-track patients.
A single agent technique was used by 92% (200/216) of respondents for nonfast-track patients, and 91% (192/211) for fast-track patients.
Pancuronium, either singly, or in combination with another NDMR, was the preferred agent by 74% (160/216) of respondents for non-fast-track patients, and 54% (113/211) for fasttrack patients. This is a highly significant difference in usage (P=0.00001).
Rocuronium was the next most preferred NDMR and its use as a single agent increased from 19% (41/216) to 26% (54/211) between non-fast-track and fast-track patients (P=0.105). Use of vecuronium increased from 6% to12% and atracurium from 0.5% to 6% on a similar basis.
There were 211 responses where a direct comparison could be made between an individual anaesthetist's management of fast-track and non-fasttrack patients. These responses indicated that 23% (49/211) change technique. For those respondents who did change their technique, 86% (42/49) excluded pancuronium from their practice between non-fast-track and fast-track patients. This change in practice is highly significant (P=0.00002).
Reasons for choice of non-depolarising muscle relaxant were analysed for pancuronium, vecuronium and rocuronium. The most consistent significant reason for change in choice of NDMR between fast-track and nonfast-track patients was duration of action (pancuronium P<0.0001; vecuronium P=0.017; rocuronium P=0.0056).
32% (46/142) of positive responses confirming the existence of a formal extubation protocol indicated that an assessment of neuromuscular function formed part of this protocol. This population represented only 21% (46/217) of total valid responses.
Only 5% (10/217) respondents indicated that an objective measure of neuromuscular function (i.e. by using a neuromuscular function monitor) formed part of an extubation protocol, whether alone or in conjunction with clinical methods.
The variety of methods used to assess neuromuscular function prior to extubation is presented in Figure 2 .
Discussion
We obtained a response rate of 73% from consultant cardiac anaesthetists actively involved in this area of clinical practice, and therefore believe that the results are representative of current practice in the UK.
Pancuronium was the single most preferred NDMR in use for both fast-track and non-fast-track patients. The reasons why pancuronium remains popular amongst cardiac anaesthetists were duration of action, personal experience with this agent and its modest cost. However, there is a significant shift to using shorter acting NDMR's for fast-track patients; shorter duration of action of these agents was the significant reason for anaesthetists making this change. Twenty percent of anaesthetists in this survey were identified as specifically changing their practice by excluding pancuronium for fast-track patients.
These results demonstrate that there was clinical appreciation amongst a minority of cardiac anaesthetists of the disparity between length of action of NDMRs and the anticipated period of ventilation. Conversely, the majority chose not to change their choice of NDMR when managing fast-track patients, despite an anticipated shorter time to extubation.
Guidelines exist for best practice regarding the safe use of muscle relaxants [10] . Increased morbidity and mortality has been demonstrated when extubation is undertaken with residual neuromuscular blockade [5] [6] [7] [8] [9] . Our survey has demonstrated that only a minority of patients are being managed within a protocol that includes some assessment of neuromuscular function prior to extubation. Recognising that using clinical methods of assessing neuromuscular function can be unreliable [11] [12] [13] , it is of concern that only 5% of respondents describe an objective assessment of neuromuscular function as forming part of an extubation protocol.
A similar USA survey [14] conducted independently and concurrently with this 
Conclusions
This postal survey of consultant cardiac anaesthetists demonstrates that the long-acting muscle relaxant pancuronium was frequently administered to fast-track cardiac surgical patients. Neuromuscular blockade was rarely monitored in this patient population, either intraoperatively, or prior to extubation.
It is concerning that these practices may be exposing this patient population to a significant risk of residual neuromuscular blockade at extubation. Therefore, we are presenting available evidence to UK cardiac anaesthetists and will resurvey to examine whether highlighting this issue has had any impact on clinical practice. 
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